Induction of anti-tumor activity following autologous stem cell transplantation: immunotherapeutic implications.
Marin
G H
GH
C.U.C.A.I.B.A., Ministry of Health, Buenos Aires, Argentina.
Menna
M E
ME
Bergna
M I
MI
Malacalza
J
J
Martin
C
C
Mendez
M C
MC
Klein
G
G
Montero-Labat
L
L
Gil
M A
MA
Saba
S
S
Gardenal
L
L
Mansilla
E
E
Orlando
S
S
Canepa
C
C
Piccinelli
G
G
D000208:Acute Disease; D000328:Adult; D005260:Female; D006086:Graft vs Host Disease / Q000175:diagnosis / Q000276:immunology*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007111:Immunity, Cellular; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000276:immunology / Q000628:therapy; D007951:Leukemia, Myeloid / Q000276:immunology / Q000628:therapy; D008223:Lymphoma / Q000276:immunology / Q000628:therapy; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000276:immunology / Q000628:therapy; D011446:Prospective Studies; D013601:T-Lymphocytes / Q000276:immunology*; D014182:Transplantation, Autologous